KBI Biopharma · 5 hours ago
Senior Accountant
KBI Biopharma is a global contract development and manufacturing organization (CDMO) providing integrated drug development and biologics manufacturing services. The Senior Accountant will play a pivotal role in driving financial excellence, combining technical accounting expertise with strategic business partnership to support critical business decisions.
BiopharmaBiotechnologyHealth CareManufacturing
Responsibilities
Financial Analysis and Strategic Partnership
Leverage advanced analytical skills to extract, analyze, and interpret large datasets from multiple ERP systems (MS Dynamics GP, ASCTrac, SAP) to identify trends, risks, and opportunities
Provide financial insights and decision support to cross-functional partners including FP&A, Procurement, Operations, and IT on complex business issues
Lead ad-hoc financial analyses and modeling to support strategic initiatives, capital projects, and process improvements
Translate complex financial concepts into actionable insights for non-finance stakeholders across the organization
Participate in system implementations and process automation initiatives, contributing accounting and controls expertise
Ensure accuracy and completeness of financial reporting through detailed reconciliations, journal entry preparation, and month-end close activities
Support external audit and SOX compliance requirements by maintaining robust documentation and internal controls
Drive continuous improvement in data integrity, financial processes, and reporting efficiency
Collaborate on special projects including SAP migration planning, data analytics initiatives, and accounting policy implementation
Analyze manufacturing cost structures, standard cost variances, and absorption costing to support pricing decisions and margin analysis
Partner with Operations and Supply Chain to investigate inventory discrepancies, implement process improvements, and ensure accurate inventory valuation
Support external audit requirements for inventory, including providing detailed support for reserves, roll-forwards, and significant transactions
Prepare technical accounting memos documenting inventory accounting policies and significant judgments
Qualification
Required
CPA (or in progress) with a bachelor's degree in accounting or finance
3+ years of progressive experience, combining Big 4 or large public accounting audit with relevant industry experience. Life Sciences, Biotechnology, Pharma, or Medical Device background is a significant advantage
Proven ability to use data analytics and visualization tools to solve problems and tell a compelling story. You do not just report numbers; you diagnose their cause and predict their future
Superior verbal and written communication skills, a business-partner mentality, unwavering attention to detail, and a proactive desire to grow into a leadership role
Ability to work under tight deadlines in a changing environment and deliver results on timely manner
Preferred
Experience with ERP systems (e.g., SAP, Oracle)
A genuine interest in leveraging technology (AI, automation, RPA) to improve financial processes and outputs
Benefits
Annual bonus structure for all employees
Medical, dental, and vision coverage
Paid PTO and holidays
Sabbatical program
401K matching with 100% vesting in 60 days
Employee recognition programs
Company
KBI Biopharma
KBI Biopharma, Inc. (KBI) is a leading development and contract manufacturing organization serving the biopharmaceutical industry. We help
H1B Sponsorship
KBI Biopharma has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (27)
2024 (11)
2023 (18)
2022 (26)
2021 (14)
2020 (21)
Funding
Current Stage
Late StageTotal Funding
$109.47MKey Investors
JSR
2025-10-01Corporate Round· $99.87M
2016-12-08Series Unknown
2009-09-22Series Unknown· $9.6M
Recent News
Kalaris Therapeutics, Inc.
2025-11-14
Company data provided by crunchbase